Today: 9 April 2026
Wesfarmers stock (ASX:WES) ends at A$81 — the next dates investors are circling
10 January 2026
1 min read

Wesfarmers stock (ASX:WES) ends at A$81 — the next dates investors are circling

Sydney, Jan 10, 2026, 17:24 AEDT — Market closed

  • Wesfarmers last traded at A$81.06 on Friday, up 0.12%.
  • The ASX 200 finished almost flat, with Rio Tinto’s slide offsetting gains in energy.
  • Inflation data due Jan 28 and Wesfarmers’ Feb 19 half-year results are next markers.

Wesfarmers Limited (WES.AX) shares ended Friday up 0.12% at A$81.06, a small lift ahead of Monday’s open on the Australian market.

The stock is a clean read on the household in Australia: a lot of shopping baskets, a lot of home projects. When rate expectations swing, retailers like Wesfarmers can get dragged with them, even without fresh company news.

That matters right now because the debate has shifted back to how long policy stays tight, not just when it loosens. Higher borrowing costs hit consumers first and they usually hit discretionary spend next.

The benchmark ASX 200 slipped 3 points to 8,716 on Friday after Rio Tinto fell 6.2%, leaving materials down 0.9% on the day even as energy gained 1.9%.

Wesfarmers traded between A$80.73 and A$81.71 on Friday, with about 1.04 million shares changing hands. The stock is inside a 52-week range of A$67.70 to A$95.18 and trades at about 31 times trailing earnings (its price-to-earnings ratio), market data showed. StockAnalysis

Kyle Rodda, a senior financial market analyst at Capital.com, said the prospect of Reserve Bank of Australia rate hikes is “a headwind” for parts of the market. He pointed to “underwhelming growth but high and possibly rising interest rates” as the problem mix, and noted the RBA’s cash rate — the benchmark that feeds into mortgage and business lending rates — is 3.6%. Indo Premier

Wesfarmers runs a mix of retail and industrial businesses, from Bunnings and Kmart to chemicals and a health division, which can soften the blows when one pocket of spending turns.

But the set-up cuts both ways. If inflation proves stubborn and borrowing costs rise again, shoppers can pull back fast, and the market can re-rate consumer stocks lower — meaning investors pay less for each dollar of profit.

The next big markers are on the calendar: the ABS is due to publish December CPI on Jan 28 and the RBA meets Feb 2–3, before Wesfarmers’ half-year results on Feb 19, where investors will look for updates on Bunnings sales, Kmart margins and costs. wesfarmers.com.au

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Zip Co stock ends week up 4% as traders turn to Feb results and US growth
Previous Story

Zip Co stock ends week up 4% as traders turn to Feb results and US growth

South32 stock near a 2026 high as dividend dates land; traders eye Feb 12 results
Next Story

South32 stock near a 2026 high as dividend dates land; traders eye Feb 12 results

Go toTop